MarketCap
Facebook
X
TelegramQuarterly report 2022-Q4
added 11-07-2022
Allscripts Healthcare Solutions Operating Expenses 2011-2026 | MDRX
Annual Operating Expenses Allscripts Healthcare Solutions
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 622 M | 701 M | 746 M | 740 M | 607 M | 547 M | 583 M | 651 M | 582 M | 529 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 746 M | 529 M | 631 M |
Quarterly Operating Expenses Allscripts Healthcare Solutions
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 352 M | - | - | - | 311 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 352 M | 311 M | 331 M |
Operating Expenses of other stocks in the Health information services industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cerner Corporation
CERN
|
4.06 B | - | - | $ 27.9 B |  USA |
 |
Computer Programs and Systems
CPSI
|
115 M | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
867 M | - | - | $ 2.94 B | USA |
 |
Change Healthcare
CHNG
|
2.99 B | - | - | $ 9.03 B | USA |
 |
Accolade
ACCD
|
123 M | - | 0.29 % | $ 206 M | USA |
 |
Castlight Health, Inc.
CSLT
|
107 M | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
123 M | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
428 M | - | - | $ 6.37 B | USA |
 |
Evolent Health
EVH
|
384 M | $ 3.93 | 4.11 % | $ 368 M | USA |
 |
Akerna Corp.
KERN
|
48.6 M | - | - | $ 161 M | USA |
 |
Health Catalyst
HCAT
|
211 M | $ 2.2 | -4.76 % | $ 132 M | USA |
 |
HealthStream
HSTM
|
136 M | $ 21.27 | -2.48 % | $ 646 M | USA |
 |
iCAD
ICAD
|
22.9 M | - | - | $ 102 M | USA |
 |
HealthEquity
HQY
|
124 M | $ 84.42 | -1.11 % | $ 7.22 B | USA |
 |
American Well Corporation
AMWL
|
164 M | $ 4.64 | -2.52 % | $ 69.6 M | USA |
 |
MTBC
MTBC
|
102 M | - | -0.58 % | $ 51.7 M | USA |
 |
1Life Healthcare
ONEM
|
217 M | - | - | $ 3.37 B | USA |
 |
So-Young International
SY
|
1.4 B | $ 2.69 | 0.56 % | $ 214 M |  China |
 |
GoodRx Holdings
GDRX
|
797 M | $ 2.6 | -3.17 % | $ 1 B | USA |
 |
OptimizeRx Corporation
OPRX
|
69.3 M | $ 11.92 | -1.89 % | $ 204 M | USA |
 |
Omnicell
OMCL
|
471 M | $ 49.14 | -2.73 % | $ 2.26 B | USA |
 |
Premier
PINC
|
742 M | - | - | $ 2.33 B | USA |
 |
Progyny
PGNY
|
47.6 M | $ 25.33 | 3.3 % | $ 2.17 B | USA |
 |
Phreesia
PHR
|
95.4 M | $ 15.64 | -4.58 % | $ 853 M | USA |
 |
R1 RCM
RCM
|
102 M | - | - | $ 3.81 B | USA |
 |
Zhongchao
ZCMD
|
9.76 M | $ 0.48 | -3.92 % | $ 2.5 M | China |
 |
Schrödinger
SDGR
|
341 M | $ 16.37 | -2.5 % | $ 1.19 B | USA |
 |
NantHealth
NH
|
89.5 M | - | -46.64 % | $ 10.4 M | USA |
 |
NextGen Healthcare
NXGN
|
269 M | - | - | $ 1.6 B | USA |
 |
10x Genomics
TXG
|
675 M | $ 22.12 | 7.77 % | $ 2.59 B | USA |
 |
Streamline Health Solutions
STRM
|
14.5 M | - | - | $ 21.4 M | USA |
 |
Teladoc Health
TDOC
|
443 M | $ 6.08 | -3.18 % | $ 1.04 B | USA |
 |
Tabula Rasa HealthCare
TRHC
|
136 M | - | - | $ 255 M | USA |
 |
Veeva Systems
VEEV
|
1.26 B | $ 215.95 | -2.82 % | $ 34.7 B | USA |
 |
SCWorx Corp.
WORX
|
2.01 M | $ 0.18 | -2.23 % | $ 263 K | USA |